CA125: Holy Grail or a Poisoned Chalice
- 8 April 2005
- journal article
- other
- Published by S. Karger AG in Nephron Clinical Practice
- Vol. 100 (2) , c52-c54
- https://doi.org/10.1159/000085033
Abstract
Identifying easily measurable markers that are of prognostic value in predicting membrane failure in peritoneal dialysis (PD) patients remains one of the major challenges. Facilitating this endeavour has always been the ease of sampling of drained peritoneal effluent within which, with the development of ever more sensitive measurement techniques, any number of mediators can be quantitated. Local production of these ‘factors’ (i.e. of peritoneal membrane or infiltrating leucocyte origin) would then theoretically, at least, allow changes to be correlated with clinical outcomes and thereby their usefulness as indicators of altered membrane status. So far then there is an attractiveness and inescapable logic to this type of approach that would predict that after almost 20 years of investigation (since the first measurements of prostaglandins in peritoneal effluent [1, 2]) there would now be sufficient data on a number of markers predictive of clinical and membrane-associated changes in these patients. Unfortunately, however, despite significant scientific endeavour (and as we will discuss a number of long-term clinical studies) we are really little nearer to identifying our holy grail.Keywords
This publication has 15 references indexed in Scilit:
- Limitations of CA125 as an Index of Peritoneal Mesothelial Cell MassNephron Clinical Practice, 2005
- The Euro-Balance Trial: The effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membraneKidney International, 2004
- Molecular Cloning of the CA125 Ovarian Cancer AntigenJournal of Biological Chemistry, 2001
- Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levelsKidney International, 2001
- Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation productsKidney International, 2001
- Longitudinal follow-up of CA125 in peritoneal effluentKidney International, 1997
- CA 125 secretion by peritoneal mesothelial cells.Journal of Clinical Pathology, 1994
- Prostaglandin-mediated loss of proteins during peritonitis in continuous ambulatory peritoneal dialysisKidney International, 1986
- Stimulation of peritoneal synthesis of vasoactive prostaglandins during peritonitis in patients on continuous ambulatory peritoneal dialysisEuropean Journal of Clinical Investigation, 1985
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981